Ars technica “The Obama administration wasted no time in overturning Bush-era executive orders, leaving many biologists excited by the prospect that current restrictions on human embryonic...
Science, Biotechnology News “Almost exactly 10 years after two groups isolated human embryonic stem cells, igniting tremendous hope for new cures, the cells are about to...
The Scientist, January 30, 2009 Read more »
Nature News “One of the world's biggest pharmaceutical companies is set to get even larger. Pfizer announced on 26 January that it intends to acquire Wyeth,...
Reuters “CHICAGO (Reuters) – U.S. researchers have reversed multiple sclerosis symptoms in early stage patients by using bone marrow stem cell transplants to reset the immune...
Nature News “US regulatory agency gives the go-ahead for first clinical trials of a human embryonic stem-cell treatment [by Geron].” Read more »
Time Magazine “Scientific inspiration can come from anywhere “Ó a person, an event, even an experiment gone awry. But perhaps nothing can drive innovation more powerfully...
NY Times “The United States Patent and Trademark Office has made a preliminary decision to revoke fundamental patents on human embryonic stem cells that some scientists...
Time, January 29, 2009 Read more »
On Tuesday, January 27th, Dr. Harold Varmus hosted a panel discussion on the future of stem cell research under the new Obama administration.
Scientific American, January 28, 2009 Read more »
NYSCF applauds the FDA approval of Geron’s pioneering human embryonic stem cell clinical trial which Tom Okarma, Geron’s president and CEO, and Hans Kierstead, of the...
January 23, 2009View Press Release »
Bio-Medicine.org “NEW YORK, January 16, 2009 – Researchers at the University of Pittsburgh School of medicine, funded by JDRF, have discovered that adult beta cells have...
Nature, Editor’s Summary “The inherited disease spinal muscular atrophy (SMA), one of the most common neurological disorders causing death in childhood, is caused by mutations in...
Nature “The board of California's state stem-cell agency has voted to pay its chairman a salary, even as the state plunges deeper into financial crisis.” Read...
Nature News “Nearly 11 years after Wisconsin-led researchers reported the first isolation of human embryonic stem cells, the field became eligible this week for broad research...
CNN.com “LONDON, England (CNN) — As well as their potential for creating effective therapies for debilitating diseases, embryonic stem cells could open the door to improved...
NYSCF-supported research by Dr. Kevin Eggan, a NYSCF advisor and researcher at the Harvard Stem Cell Institute, resulting in the first-ever human stem cell lines from...
Receives Presidential Early Career Award for Scientists and Engineers
Science, December 19, 2008 Read more »
CHI Insight Pharma Reports “According to a new analysis from Insight Pharma Reports, a leading biotech and pharmaceutical business intelligence provider, several trends are converging toward...
In another exciting breakthrough, Dr. Kevin Eggan, Chief Scientific Officer of The New York Stem Cell Foundation and Principal Faculty Member of the Harvard Stem Cell...
Guardian.co.uk “Duke University study shows that 41% of patients who finished fertility treatment consider donating embryos.” Read more »
Nature “Human embyronic stem cells whose derivation requires the destruction of embryos cannot be patented, the appeals board of the European Patent Office (EPO) ruled on...
